Skip to main content
Top
Published in: Journal of Translational Medicine 1/2021

Open Access 01-12-2021 | SARS-CoV-2 | Research

Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection

Authors: Yunxian Liu, Joseph E. Ebinger, Rowann Mostafa, Petra Budde, Jana Gajewski, Brian Walker, Sandy Joung, Min Wu, Manuel Bräutigam, Franziska Hesping, Elena Rupieper, Ann-Sophie Schubert, Hans-Dieter Zucht, Jonathan Braun, Gil Y. Melmed, Kimia Sobhani, Moshe Arditi, Jennifer E. Van Eyk, Susan Cheng, Justyna Fert-Bober

Published in: Journal of Translational Medicine | Issue 1/2021

Login to get access

Abstract

Background

Pronounced sex differences in the susceptibility and response to SARS-CoV-2 infection remain poorly understood. Emerging evidence has highlighted the potential importance of autoimmune activation in modulating the acute response and recovery trajectories following SARS-CoV-2 exposure. Given that immune-inflammatory activity can be sex-biased in the setting of severe COVID-19 illness, the aim of the study was to examine sex-specific autoimmune reactivity to SARS-CoV-2 in the absence of extreme clinical disease.

Methods

In this study, we assessed autoantibody (AAB) reactivity to 91 autoantigens previously linked to a range of classic autoimmune diseases in a cohort of 177 participants (65% women, 35% men, mean age of 35) with confirmed evidence of prior SARS-CoV-2 infection based on presence of antibody to the nucleocapsid protein of SARS-CoV-2. Data were compared to 53 pre-pandemic healthy controls (49% women, 51% men). For each participant, socio-demographic data, serological analyses, SARS-CoV-2 infection status and COVID-19 related symptoms were collected by  an electronic survey of questions. The symptoms burden score was constructed based on the total number of reported symptoms (N = 21) experienced within 6 months prior to the blood draw, wherein a greater number of symptoms corresponded to a higher score and assigned as more severe burden.

Results

In multivariable analyses, we observed sex-specific patterns of autoreactivity associated with the presence or absence (as well as timing and clustering of symptoms) associated with prior COVID-19 illness. Whereas the overall AAB response was more prominent in women following asymptomatic infection, the breadth and extent of AAB reactivity was more prominent in men following at least mildly symptomatic infection. Notably, the observed reactivity included distinct antigens with molecular homology with SARS-CoV-2.

Conclusion

Our results reveal that prior SARS-CoV-2 infection, even in the absence of severe clinical disease, can lead to a broad AAB response that exhibits sex-specific patterns of prevalence and antigen selectivity. Further understanding of the nature of triggered AAB activation among men and women exposed to SARS-CoV-2 will be essential for developing effective interventions against immune-mediated sequelae of COVID-19.
Appendix
Available only for authorised users
Literature
1.
go back to reference Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442–7.CrossRef Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442–7.CrossRef
2.
go back to reference Lerma LA, et al. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun. 2020;3:100073.CrossRef Lerma LA, et al. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun. 2020;3:100073.CrossRef
3.
go back to reference Bhadelia N, et al. Distinct autoimmune antibody signatures between hospitalized acute COVID-19 patients, SARS-CoV-2 convalescent individuals, and unexposed pre-pandemic controls [preprint]. medRxiv. 2021;2021.2001.2021.21249176. Bhadelia N, et al. Distinct autoimmune antibody signatures between hospitalized acute COVID-19 patients, SARS-CoV-2 convalescent individuals, and unexposed pre-pandemic controls [preprint]. medRxiv. 2021;2021.2001.2021.21249176.
4.
go back to reference Wehbe Z, et al. Molecular and biological mechanisms underlying gender differences in COVID-19 Severity and Mortality. Front Immunol. 2021;12:659339.CrossRef Wehbe Z, et al. Molecular and biological mechanisms underlying gender differences in COVID-19 Severity and Mortality. Front Immunol. 2021;12:659339.CrossRef
5.
go back to reference Ebinger JE, et al. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ open. 2021;11:e043584.CrossRef Ebinger JE, et al. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ open. 2021;11:e043584.CrossRef
6.
go back to reference Bryan A, et al. Performance characteristics of the abbott architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020;58:e00941.CrossRef Bryan A, et al. Performance characteristics of the abbott architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho. J Clin Microbiol. 2020;58:e00941.CrossRef
7.
go back to reference Ebinger JE, et al. SARS-CoV-2 seroprevalence in relation to timing of symptoms. medRxiv. 2020;2020.2008.2002.20166876 Ebinger JE, et al. SARS-CoV-2 seroprevalence in relation to timing of symptoms. medRxiv. 2020;2020.2008.2002.20166876
8.
go back to reference Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.CrossRef Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.CrossRef
9.
go back to reference Günther A, Becker M, Göpfert J, Joos T, Schneiderhan-Marra N. Comparison of bead-based fluorescence versus planar electrochemiluminescence multiplex immunoassays for measuring cytokines in human plasma. Front Immunol. 2020;11:572634.CrossRef Günther A, Becker M, Göpfert J, Joos T, Schneiderhan-Marra N. Comparison of bead-based fluorescence versus planar electrochemiluminescence multiplex immunoassays for measuring cytokines in human plasma. Front Immunol. 2020;11:572634.CrossRef
10.
go back to reference Budde P, et al. Multiparametric detection of autoantibodies in systemic lupus erythematosus. Lupus. 2016;25:812–22.CrossRef Budde P, et al. Multiparametric detection of autoantibodies in systemic lupus erythematosus. Lupus. 2016;25:812–22.CrossRef
11.
go back to reference Yan M, Ye K. Determining the number of clusters using the weighted gap statistic. Biometrics. 2007;63:1031–7.CrossRef Yan M, Ye K. Determining the number of clusters using the weighted gap statistic. Biometrics. 2007;63:1031–7.CrossRef
12.
go back to reference Griffith DM, Veech JA, Marsh CJ. cooccur: probabilistic species co-occurrence analysis in R. J Stat Softw Code Snippets. 2016;69:1–17. Griffith DM, Veech JA, Marsh CJ. cooccur: probabilistic species co-occurrence analysis in R. J Stat Softw Code Snippets. 2016;69:1–17.
13.
go back to reference Fukushima H, et al. Diagnosis and discrimination of autoimmune Graves’ disease and Hashimoto’s disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes. J Biosci Bioeng. 2009;108:551–6.CrossRef Fukushima H, et al. Diagnosis and discrimination of autoimmune Graves’ disease and Hashimoto’s disease using thyroid-stimulating hormone receptor-containing recombinant proteoliposomes. J Biosci Bioeng. 2009;108:551–6.CrossRef
14.
go back to reference Wei Y, et al. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. Blood Adv. 2018;2:2491–504.CrossRef Wei Y, et al. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. Blood Adv. 2018;2:2491–504.CrossRef
15.
go back to reference Marvin Josué Bustamante G, et al. Mixed connective tissue disease (MCTD): 6 case based review. 2020. Marvin Josué Bustamante G, et al. Mixed connective tissue disease (MCTD): 6 case based review. 2020.
16.
go back to reference Kattah NH, Kattah MG, Utz PJ. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev. 2010;233:126–45.CrossRef Kattah NH, Kattah MG, Utz PJ. The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases. Immunol Rev. 2010;233:126–45.CrossRef
17.
go back to reference Betancur JF, et al. Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations. Medicine. 2018;97:e11727–e11727.CrossRef Betancur JF, et al. Uncommon patterns of antinuclear antibodies recognizing mitotic spindle apparatus antigens and clinical associations. Medicine. 2018;97:e11727–e11727.CrossRef
18.
go back to reference Fregeau DR, et al. Inhibition of α-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. Hepatology. 1990;11:975–81.CrossRef Fregeau DR, et al. Inhibition of α-ketoglutarate dehydrogenase activity by a distinct population of autoantibodies recognizing dihydrolipoamide succinyltransferase in primary biliary cirrhosis. Hepatology. 1990;11:975–81.CrossRef
19.
go back to reference Choi J, Hwang S-Y, Ahn K. Interplay between RNASEH2 and MOV10 controls LINE-1 retrotransposition. Nucleic Acids Res. 2018;46:1912–26.CrossRef Choi J, Hwang S-Y, Ahn K. Interplay between RNASEH2 and MOV10 controls LINE-1 retrotransposition. Nucleic Acids Res. 2018;46:1912–26.CrossRef
20.
go back to reference Wang X, et al. Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J Biol Chem. 2010;285:14346–55.CrossRef Wang X, et al. Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J Biol Chem. 2010;285:14346–55.CrossRef
21.
go back to reference Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. J Autoimmun. 2021;120:102644.CrossRef Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19. J Autoimmun. 2021;120:102644.CrossRef
22.
go back to reference Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya J-M. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;2012:254319.PubMedPubMedCentral Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, Mantilla RD, Anaya J-M. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;2012:254319.PubMedPubMedCentral
23.
go back to reference Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283–8.CrossRef Wang EY, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283–8.CrossRef
24.
go back to reference Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology. 2005;44:975–82.CrossRef Riemekasten G, Hahn BH. Key autoantigens in SLE. Rheumatology. 2005;44:975–82.CrossRef
25.
go back to reference Daamen AR, et al. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021;11:7052.CrossRef Daamen AR, et al. Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway. Sci Rep. 2021;11:7052.CrossRef
26.
go back to reference Moreno-Rubio J, et al. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer. Cancer Biol Med. 2020;17:444–57.CrossRef Moreno-Rubio J, et al. Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer. Cancer Biol Med. 2020;17:444–57.CrossRef
27.
go back to reference Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–32.CrossRef Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–32.CrossRef
28.
go back to reference Jin J-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef Jin J-M, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.CrossRef
29.
go back to reference Ebinger JE, et al. Pre-existing traits associated with Covid-19 illness severity. PloS ONE. 2020;15:e0236240.CrossRef Ebinger JE, et al. Pre-existing traits associated with Covid-19 illness severity. PloS ONE. 2020;15:e0236240.CrossRef
30.
go back to reference Lau ES, et al. Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: insights from the MGH COVID-19 patient registry. PLoS ONE. 2021;16:e0250774–e0250774.CrossRef Lau ES, et al. Sex differences in inflammatory markers in patients hospitalized with COVID-19 infection: insights from the MGH COVID-19 patient registry. PLoS ONE. 2021;16:e0250774–e0250774.CrossRef
31.
go back to reference Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173:600–9.CrossRef Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173:600–9.CrossRef
32.
go back to reference Billi AC, Kahlenberg JM, Gudjonsson JE. Sex bias in autoimmunity. Curr Opin Rheumatol. 2019;31:53–61.CrossRef Billi AC, Kahlenberg JM, Gudjonsson JE. Sex bias in autoimmunity. Curr Opin Rheumatol. 2019;31:53–61.CrossRef
33.
go back to reference Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53:487–95.CrossRef Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53:487–95.CrossRef
34.
Metadata
Title
Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection
Authors
Yunxian Liu
Joseph E. Ebinger
Rowann Mostafa
Petra Budde
Jana Gajewski
Brian Walker
Sandy Joung
Min Wu
Manuel Bräutigam
Franziska Hesping
Elena Rupieper
Ann-Sophie Schubert
Hans-Dieter Zucht
Jonathan Braun
Gil Y. Melmed
Kimia Sobhani
Moshe Arditi
Jennifer E. Van Eyk
Susan Cheng
Justyna Fert-Bober
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2021
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-021-03184-8

Other articles of this Issue 1/2021

Journal of Translational Medicine 1/2021 Go to the issue